z-logo
Premium
Biologics in the Treatment of Chronic Pain: A New Era of Therapy?
Author(s) -
Bannwarth B,
Kostine M
Publication year - 2015
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.20
Subject(s) - tolerability , medicine , chronic pain , pain relief , intensive care medicine , nerve growth factor , physical therapy , anesthesia , adverse effect , pharmacology , receptor
Existing analgesics fail to provide adequate pain relief in a significant proportion of patients complaining of chronic pain. Furthermore, their use is limited by tolerability and safety concerns. Thus, there is a huge unmet need for effective and safe innovative painkillers. Considering the major role of nerve growth factor (NGF) in the generation and maintenance of a wide range of pain states, the issue is whether anti‐NGF biologics under development might offer such an opportunity.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here